GRAL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026

Faruqi & Faruqi, LLP is investigating securities fraud claims against Grail, Inc. (NASDAQ: GRAL) for allegedly making false and misleading statements about its NHS-Galleri cancer detection trial. The company touted confidence in the trial's success while concealing that the trial period was insufficient to achieve its primary endpoint. On February 19, 2026, Grail announced the primary endpoint was not observed, causing the stock to plummet 50.55% in a single day from $101.53 to $50.21 per share. Investors who purchased GRAL stock between May 13, 2025 and February 19, 2026 have until August 4, 2026 to seek lead plaintiff status.